AxoGen, Inc. (AXGN)
USD 17.13
(3.94%)
USD 17.13
(3.94%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 69.29 Million USD | 2.77% |
| 2022 | 67.42 Million USD | -0.04% |
| 2021 | 67.45 Million USD | 25.46% |
| 2020 | 53.76 Million USD | 1514.05% |
| 2019 | 3.33 Million USD | 5187.3% |
| 2018 | 63 Thousand USD | -99.74% |
| 2017 | 24.64 Million USD | 1.35% |
| 2016 | 24.31 Million USD | -4.84% |
| 2015 | 25.54 Million USD | 1.84% |
| 2014 | 25.08 Million USD | -1.1% |
| 2013 | 25.36 Million USD | 17.53% |
| 2012 | 21.58 Million USD | 346.01% |
| 2011 | 4.83 Million USD | -42.4% |
| 2010 | 8.4 Million USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 2525.00 USD | -99.14% |
| 2003 | 295 Thousand USD | -74.68% |
| 2002 | 1.16 Million USD | 9.51% |
| 2001 | 1.06 Million USD | 19.37% |
| 2000 | 891.28 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | -100.0% |
| 1990 | 800 Thousand USD | -38.46% |
| 1989 | 1.3 Million USD | 160.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 69.02 Million USD | -0.17% |
| 2024 Q1 | 69.15 Million USD | -0.2% |
| 2023 Q1 | 67.07 Million USD | -0.53% |
| 2023 Q4 | 69.29 Million USD | 2.81% |
| 2023 Q3 | 67.4 Million USD | 0.11% |
| 2023 FY | 69.29 Million USD | 2.77% |
| 2023 Q2 | 67.32 Million USD | 0.38% |
| 2022 FY | 67.42 Million USD | -0.04% |
| 2022 Q1 | 67.99 Million USD | 0.8% |
| 2022 Q4 | 67.42 Million USD | -0.33% |
| 2022 Q3 | 67.65 Million USD | -0.04% |
| 2022 Q2 | 67.68 Million USD | -0.46% |
| 2021 Q2 | 68.21 Million USD | 25.59% |
| 2021 Q4 | 67.45 Million USD | -2.5% |
| 2021 FY | 67.45 Million USD | 25.46% |
| 2021 Q1 | 54.31 Million USD | 1.02% |
| 2021 Q3 | 69.18 Million USD | 1.42% |
| 2020 FY | 53.76 Million USD | 1514.05% |
| 2020 Q1 | 2.97 Million USD | -10.72% |
| 2020 Q2 | 33.51 Million USD | 1026.87% |
| 2020 Q3 | 53.29 Million USD | 59.02% |
| 2020 Q4 | 53.76 Million USD | 0.89% |
| 2019 Q1 | 4.58 Million USD | 7176.19% |
| 2019 Q2 | 4.21 Million USD | -8.09% |
| 2019 Q3 | 3.77 Million USD | -10.4% |
| 2019 Q4 | 3.33 Million USD | -11.76% |
| 2019 FY | 3.33 Million USD | 5187.3% |
| 2018 Q4 | 63 Thousand USD | -15.18% |
| 2018 Q3 | 74.27 Thousand USD | -11.86% |
| 2018 Q2 | 84.26 Thousand USD | -99.66% |
| 2018 Q1 | 24.58 Million USD | -0.22% |
| 2018 FY | 63 Thousand USD | -99.74% |
| 2017 Q3 | 24.37 Million USD | 0.87% |
| 2017 FY | 24.64 Million USD | 1.35% |
| 2017 Q4 | 24.64 Million USD | 1.07% |
| 2017 Q2 | 24.16 Million USD | -0.44% |
| 2017 Q1 | 24.27 Million USD | -0.15% |
| 2016 Q3 | 24.99 Million USD | 0.18% |
| 2016 Q1 | 24.8 Million USD | -2.91% |
| 2016 FY | 24.31 Million USD | -4.84% |
| 2016 Q4 | 24.31 Million USD | -2.74% |
| 2016 Q2 | 24.95 Million USD | 0.6% |
| 2015 Q3 | 25.53 Million USD | 0.44% |
| 2015 Q2 | 25.42 Million USD | 0.62% |
| 2015 Q1 | 25.26 Million USD | 0.73% |
| 2015 FY | 25.54 Million USD | 1.84% |
| 2015 Q4 | 25.54 Million USD | 0.04% |
| 2014 FY | 25.08 Million USD | -1.1% |
| 2014 Q3 | 28.17 Million USD | 3.42% |
| 2014 Q2 | 27.24 Million USD | 3.76% |
| 2014 Q1 | 26.25 Million USD | 3.52% |
| 2014 Q4 | 25.08 Million USD | -10.96% |
| 2013 Q4 | 25.36 Million USD | 4.24% |
| 2013 Q3 | 24.33 Million USD | 4.06% |
| 2013 Q2 | 23.38 Million USD | 4.21% |
| 2013 Q1 | 22.43 Million USD | 3.98% |
| 2013 FY | 25.36 Million USD | 17.53% |
| 2012 FY | 21.58 Million USD | 346.01% |
| 2012 Q4 | 21.58 Million USD | 225.73% |
| 2012 Q3 | 6.62 Million USD | 36.24% |
| 2012 Q2 | 4.86 Million USD | 0.25% |
| 2012 Q1 | 4.85 Million USD | 0.25% |
| 2011 Q1 | - USD | -100.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | 4.82 Million USD | 0.0% |
| 2011 Q4 | 4.83 Million USD | 0.25% |
| 2011 FY | 4.83 Million USD | -42.4% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | 8.4 Million USD | 0.0% |
| 2010 Q4 | 8.4 Million USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 FY | - USD | -100.0% |
| 2005 Q2 | - USD | -100.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | 1292.00 USD | -48.83% |
| 2004 Q2 | 289.09 Thousand USD | -1.09% |
| 2004 FY | 2525.00 USD | -99.14% |
| 2004 Q4 | 2525.00 USD | 0.0% |
| 2004 Q3 | - USD | -100.0% |
| 2004 Q1 | 292.26 Thousand USD | -0.93% |
| 2003 FY | 295 Thousand USD | -74.68% |
| 2003 Q4 | 295 Thousand USD | -8.69% |
| 2003 Q1 | 314.29 Thousand USD | -73.03% |
| 2003 Q2 | 283.5 Thousand USD | -9.8% |
| 2003 Q3 | 323.08 Thousand USD | 13.96% |
| 2002 Q1 | 1.03 Million USD | 0.0% |
| 2002 Q2 | 1.22 Million USD | 18.51% |
| 2002 Q3 | 1.19 Million USD | -2.47% |
| 2002 Q4 | 1.16 Million USD | -2.56% |
| 2002 FY | 1.16 Million USD | 9.51% |
| 2001 Q2 | 897.93 Thousand USD | -30.54% |
| 2001 Q3 | 886 Thousand USD | -1.33% |
| 2001 FY | 1.06 Million USD | 19.37% |
| 2001 Q1 | 1.29 Million USD | 7.18% |
| 2000 Q4 | 1.2 Million USD | 59.32% |
| 2000 Q3 | 757.08 Thousand USD | -15.06% |
| 2000 Q2 | 891.28 Thousand USD | 116.11% |
| 2000 Q1 | 412.41 Thousand USD | 0.0% |
| 2000 FY | 891.28 Thousand USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q1 | 100 Thousand USD | 0.0% |
| 1996 Q2 | - USD | -100.0% |
| 1995 Q3 | 100 Thousand USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q4 | 100 Thousand USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 FY | - USD | -100.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q2 | - USD | -100.0% |
| 1991 Q1 | 700 Thousand USD | 0.0% |
| 1990 Q2 | 800 Thousand USD | -98.3% |
| 1990 Q1 | 47 Million USD | 0.0% |
| 1990 FY | 800 Thousand USD | -38.46% |
| 1990 Q4 | 700 Thousand USD | 0.0% |
| 1990 Q3 | 700 Thousand USD | -12.5% |
| 1989 Q3 | 1.5 Million USD | 15.38% |
| 1989 FY | 1.3 Million USD | 160.0% |
| 1989 Q2 | 1.3 Million USD | 0.0% |
| 1989 Q4 | 47 Million USD | 3033.33% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| electroCore, Inc. | 626 Thousand USD | -10969.01% |
| NeuroPace, Inc. | 72.39 Million USD | 4.286% |
| Sight Sciences, Inc. | 35.41 Million USD | -95.663% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -4244.326% |
| SI-BONE, Inc. | 38.99 Million USD | -77.708% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -138.633% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | -76.675% |
| Cerus Corporation | 95.99 Million USD | 27.82% |
| Axonics, Inc. | 27.61 Million USD | -150.903% |
| 908 Devices Inc. | 5.94 Million USD | -1065.551% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 1.438% |
| TELA Bio, Inc. | 42.78 Million USD | -61.973% |
| Venus Concept Inc. | 79.69 Million USD | 13.056% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -18678.32% |
| RxSight, Inc. | 3.01 Million USD | -2200.531% |
| LENSAR, Inc. | 2.3 Million USD | -2900.953% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -843.262% |
| LivaNova PLC | 640.4 Million USD | 89.18% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -2851.107% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -354.225% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 87.208% |
| Apyx Medical Corporation | 38.5 Million USD | -79.975% |
| Cutera, Inc. | 431.91 Million USD | 83.957% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -343.242% |
| BioSig Technologies, Inc. | 452 Thousand USD | -15230.088% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 95.88% |
| Bioventus Inc. | 409.47 Million USD | 83.078% |
| Envoy Medical, Inc. | 404 Thousand USD | -17051.485% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -121464.912% |
| Outset Medical, Inc. | 136.18 Million USD | 49.12% |
| Nexalin Technology, Inc. | 4463.00 USD | -1552487.945% |
| IRIDEX Corporation | 2.74 Million USD | -2423.379% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 12.515% |
| IRadimed Corporation | 2.04 Million USD | -3291.608% |
| PAVmed Inc | 48.72 Million USD | -42.21% |
| INVO Bioscience, Inc. | 8.68 Million USD | -697.968% |
| Movano Inc. | 252 Thousand USD | -27396.825% |
| Cytek Biosciences, Inc. | 33.17 Million USD | -108.874% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -37477.007% |
| Spectral AI, Inc. | 1.28 Million USD | -5275.64% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -574.626% |
| Varex Imaging Corporation | 469.5 Million USD | 85.241% |
| Quipt Home Medical Corp. | 98.94 Million USD | 29.968% |
| IceCure Medical Ltd | 599 Thousand USD | -11467.947% |
| Pulmonx Corporation | 41.42 Million USD | -67.275% |
| Modular Medical, Inc. | 1.19 Million USD | -5722.857% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -26347.328% |
| Insulet Corporation | 1.44 Billion USD | 95.217% |
| Semler Scientific, Inc. | 70 Thousand USD | -98888.571% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -397.038% |
| Orthofix Medical Inc. | 134.19 Million USD | 48.366% |
| InMode Ltd. | 9.01 Million USD | -668.46% |
| Bruker Corporation | 1.37 Billion USD | 94.977% |
| Surmodics, Inc. | 29.4 Million USD | -135.647% |
| Cytosorbents Corporation | 18.31 Million USD | -278.373% |
| iCAD, Inc. | 461 Thousand USD | -14930.803% |
| DexCom, Inc. | 2.59 Billion USD | 97.329% |
| Align Technology, Inc. | 96.96 Million USD | 28.541% |
| ZimVie Inc. | 521.92 Million USD | 86.724% |
| Nexalin Technology, Inc. | 4463.00 USD | -1552487.945% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -3370.674% |
| BrainsWay Ltd. | 471 Thousand USD | -14611.677% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 83.33% |
| Profound Medical Corp. | 7.9 Million USD | -777.073% |
| enVVeno Medical Corporation | 1.4 Million USD | -4842.368% |
| Nuwellis, Inc. | 981 Thousand USD | -6963.405% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -725.298% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -7269.012% |
| Inogen, Inc. | 21.92 Million USD | -216.07% |
| MaxCyte, Inc. | 18.74 Million USD | -269.695% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 46.626% |
| OrthoPediatrics Corp. | 23.76 Million USD | -191.633% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -3370.674% |
| InspireMD, Inc. | 1.59 Million USD | -4244.326% |
| PAVmed Inc. | 48.72 Million USD | -42.21% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -13983.997% |
| BIOLASE, Inc. | 17.91 Million USD | -286.89% |
| Beyond Air, Inc. | 17.83 Million USD | -288.473% |
| FONAR Corporation | 41.67 Million USD | -66.264% |
| Vivani Medical, Inc. | 20.69 Million USD | -234.809% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | -37.552% |
| Inari Medical, Inc. | 32.04 Million USD | -116.22% |
| UFP Technologies, Inc. | 46.03 Million USD | -50.514% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -2156.288% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -6586.236% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -2217.019% |
| Tenon Medical, Inc. | 1.17 Million USD | -5807.246% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -6815.369% |
| CVRx, Inc. | 30.61 Million USD | -126.348% |
| AdaptHealth Corp. | 2.29 Billion USD | 96.98% |
| Sintx Technologies, Inc. | 4.24 Million USD | -1532.32% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -3373.283% |
| NanoVibronix, Inc. | 5000.00 USD | -1385740.0% |
| Quanterix Corporation | 41.46 Million USD | -67.114% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -2851.107% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -8749.553% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 92.581% |
| TransMedics Group, Inc. | 515.94 Million USD | 86.57% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -3541.198% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -28666.668% |
| Hyperfine, Inc. | 185 Thousand USD | -37355.135% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 63.952% |
| Biomerica, Inc. | 785 Thousand USD | -8727.006% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -15315.933% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -18622.254% |
| Silk Road Medical, Inc | 84.63 Million USD | 18.126% |